Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 14, 2013 16:20 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2013

NORTHVALE, N.J., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
February 13, 2013 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Third Quarter Investor Conference Call on Tuesday, February 19, 2013

NORTHVALE, N.J., Feb. 13, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
February 06, 2013 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone

NORTHVALE, N.J., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that on January 31, 2012, the U.S. Food and Drug Administration approved the...
January 28, 2013 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces First Shipments From Expanded 15,000 Square Foot Facility

NORTHVALE, N.J., Jan. 28, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that Elite is now using and shipping packaged product from its...
December 13, 2012 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces Agreement for Supply of Phentermine Active Ingredient

NORTHVALE, N.J., Dec. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that Elite has in place an agreement for the next year with the...
December 10, 2012 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Amendment to Bridge Loan Facility

NORTHVALE, N.J., Dec. 10, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has amended the bridge loan agreement ("Loan Agreement") with Jerry...
November 15, 2012 07:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces First Shipment of Generic Phendimetrazine Tablet Product

NORTHVALE, N.J., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic...
November 14, 2012 16:44 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal 2013

NORTHVALE, N.J., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
November 13, 2012 13:34 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Second Quarter Investor Conference Call on Thursday, November 15, 2012

NORTHVALE, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
October 15, 2012 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces Approval of Phentermine Capsules and Delayed Launch

NORTHVALE, N.J., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that Elite received approval as of September 28th from the U.S....